You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

Leading Biobased Business Experts to Discuss What’s Next in Industrial Biotechnology and the Bioeconomy at the BIO 2014 Pacific Rim Summit

<p>
During the 2014 Pacific Rim Summit Plenary Program, CEOs, CSOs and industrial biotechnology industry veterans will highlight achievements and offer insight into the quickly changing and expanding markets of renewable specialty chemical applications, biobased products, advanced biofuels and algae bioproduction.&nbsp; Panelists will compare feedstock production on a global scale and discuss solutions in logistics, feedstock availability, potential for economic growth, and exploring new markets.&nbsp;</p>

Washington, D.C. (October 22, 2014) – During the 2014 Pacific Rim Summit Plenary Program, CEOs, CSOs and industrial biotechnology industry veterans will highlight achievements and offer insight into the quickly changing and expanding markets of renewable specialty chemical applications, biobased products, advanced biofuels and algae bioproduction.  Panelists will compare feedstock production on a global scale and discuss solutions in logistics, feedstock availability, potential for economic growth, and exploring new markets. The 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy will be held December 7-9, 2014 in San Diego, California at the Westin Gaslamp Quarter. 

“The plenary programming at the 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy will feature a diverse set of executives from the industrial biotechnology sector who will highlight areas for future growth of the biobased economy,” stated Brent Erickson, Vice President, Industrial and Environmental at BIO.  “This year’s Summit will offer attendees front rows seats to see experienced business leaders and executives provide a high-level look into what lies ahead for the industry.”  

Panelists and session topics for the 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy Plenary Program include:

Innovative Technologies to Transform the Biobased Economy

Industrial biotechnology thought leaders will discuss technology breakthroughs in renewable specialty chemical applications and biobased products.  

ModeratorSteve Gatto, CEO, Entrinsic Health Solutions LLC

·         Alan Shaw, CEO, Calysta

·         Jeff Martin, Co-Founder & CEO, Yulex

·         Nicolas Denis, Principal, McKinsey & Company 

 

Feedstocks: A Global Comparison

This panel will explore the realities faced by feedstock producers in today’s marketplace.  Panelists will delve into issues in production and logistics, feedstock availability, ability to scale, competing applications for feedstock use, and new markets. 

Moderator: Susan Jenkins, Managing Director, Energy Biosciences Institute (EBI)

·         Ajarin Pattanapanchai, Deputy Secretary General, Thai Investment Board

·         Timothy Volk, Senior Research Associate, SUNY College of Environmental Science and Forestry

·         Dirk Kronemeijer, Founder and Managing Director, SkyNRG (invited)

 

Green Machines: The Latest in Algae Bioproduction

Our diverse array of panelists will discuss exciting advancements in research, development, and production of algae biomass for use in fuels and other specialized applications.  

Moderator: Margaret McCormick, CEO, Matrix Genetics

·         Martin Sabarsky, CEO, Cellana

·         Jamie Levine, CEO, Sapphire Energy

·         Ami Ben-Amotz, CSO, NBT Ltd.

 

Registration deadline for Early Bird rates is Friday, October 24, 2014.  Registration and information on rates can be found here http://www.bio.org/events/conferences/pacific-rim-summit-registration

For more information on the conference, please visit http://www.bio.org/pacrim. For assistance, please contact pacrim@bio.org or 202-962-9200.

All programs at the Pacific Rim Summit on Industrial Biotechnology and Bioenergy are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.